COc1cc2c[n+](C)c3c4cc(OC)c(OCc5ccccc5)cc4c(OCc4ccccc4)cc3c2cc1OC.CS(=O)(=O)[O-]
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?